BR112022004815A2 - Suplementação de probióticos à base de esporos em cães e controle de endotoxemia - Google Patents

Suplementação de probióticos à base de esporos em cães e controle de endotoxemia

Info

Publication number
BR112022004815A2
BR112022004815A2 BR112022004815A BR112022004815A BR112022004815A2 BR 112022004815 A2 BR112022004815 A2 BR 112022004815A2 BR 112022004815 A BR112022004815 A BR 112022004815A BR 112022004815 A BR112022004815 A BR 112022004815A BR 112022004815 A2 BR112022004815 A2 BR 112022004815A2
Authority
BR
Brazil
Prior art keywords
endotoxemia
dogs
spore
control
probiotic supplementation
Prior art date
Application number
BR112022004815A
Other languages
English (en)
Inventor
M Kriz Dale
Kiran Krishnan
F Bayne Thomas
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of BR112022004815A2 publication Critical patent/BR112022004815A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

suplementação de probióticos à base de esporos em cães e controle de endotoxemia. a presente invenção é direcionada a métodos de administração de uma composição probiótica incluindo bacillus subtilis, bacillus licheniformis e pediococcus acidilactici a cães para diminuir a endotoxemia e melhorar o processo digestivo, e métodos relacionados.
BR112022004815A 2019-09-16 2020-09-16 Suplementação de probióticos à base de esporos em cães e controle de endotoxemia BR112022004815A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962900901P 2019-09-16 2019-09-16
PCT/US2020/051093 WO2021055492A1 (en) 2019-09-16 2020-09-16 Spore-based probiotic supplementation in dogs and control of endotoxemia

Publications (1)

Publication Number Publication Date
BR112022004815A2 true BR112022004815A2 (pt) 2022-06-21

Family

ID=74883735

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004815A BR112022004815A2 (pt) 2019-09-16 2020-09-16 Suplementação de probióticos à base de esporos em cães e controle de endotoxemia

Country Status (5)

Country Link
US (1) US20210128647A1 (pt)
EP (1) EP4031153A4 (pt)
CN (1) CN114423442A (pt)
BR (1) BR112022004815A2 (pt)
WO (1) WO2021055492A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117736941B (zh) * 2024-02-19 2024-04-23 山东威曼宠物食品有限公司 一种对犬骨骼有益的地衣芽孢杆菌King58及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080200A1 (en) * 2003-03-11 2004-09-23 Inatech International Inc. Probiotic micro-organisms and uses thereof
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
WO2011069860A1 (en) * 2009-12-08 2011-06-16 Chr. Hansen A/S Novel use for the treatment of metabolic endotoxemia
WO2011075138A1 (en) * 2009-12-18 2011-06-23 Hill's Pet Nutrition, Inc. Pet food compositions including probiotics and methods of manufacture and use thereof
MX348937B (es) * 2010-08-25 2017-07-03 Tate & Lyle Ingredients Americas Llc Producto simbiotico.
WO2012101167A1 (en) * 2011-01-25 2012-08-02 Austrianova Singapore Pte Ltd. Protection of microbial cells from acidic degradation
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US20150157670A1 (en) * 2013-12-06 2015-06-11 K&K Ventures, LLC Non-caloric probiotic composition and method of preparation
US20180289752A1 (en) * 2017-04-06 2018-10-11 Physician's Exclusive, LLC Spore-Based Probiotic Composition for Reduction of Dietary Endotoxemia and Related Methods
CN108371247A (zh) * 2017-11-13 2018-08-07 刘德文 一种提高仔猪存活率的复合益生菌

Also Published As

Publication number Publication date
EP4031153A1 (en) 2022-07-27
CN114423442A (zh) 2022-04-29
US20210128647A1 (en) 2021-05-06
WO2021055492A1 (en) 2021-03-25
EP4031153A4 (en) 2023-11-22

Similar Documents

Publication Publication Date Title
BR112018007453A2 (pt) genes modificados de ataxia de friedreich e vetores para a terapia gênica
CL2020001391A1 (es) Formulación liofilizada de un anticuerpo monoclonal contra la transtirretina.
BR112018016484A2 (pt) composto, composição farmacêutica, método de inibir a atividade da amina oxidase, método de tratar uma condição e uso de um composto
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
BR112015026547A2 (pt) n-(fenilcicloalquil)carboxiamidas nematicidais e n-(fenilcicloalquil)tiocarboxamidas
BR112022007677A2 (pt) L-asparaginase recombinante
BR112017006713A2 (pt) inibidor de egfr, e preparação e aplicação do mesmo
BR112017007543A2 (pt) peptídeos com propriedades anti-inflamatórias
CR20150500A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril- aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
BR112015005117A2 (pt) métodos de tratamento da doença de alzheimer e suas composições farmacêuticas
BR112018010903A2 (pt) composições compreendendo bacillus licheniformis e bacillus subtilis e métodos de uso para o controle de nematóides
UY32123A (es) Derivados de n - (sustituido) - 4 - (but-2-iniloxi) - benzamida, sus racematos, diastereòmeros, enantiòmeros y las sales de los mismos y aplicaciones
BR112013002854A2 (pt) composição nematocida compreendendo bacillus subtilis e bacillus licheniformis
CO2017005834A2 (es) Composición de liberación modificada de orlistat y acarbosa para el tratamiento de la obesidad y trastornos metabólicos relacionados
BR112015018360A2 (pt) terapia de combinação para o tratamento de pneumonia nosocomial
BR112022004815A2 (pt) Suplementação de probióticos à base de esporos em cães e controle de endotoxemia
BR112019001039A2 (pt) composição para uso no tratamento de transtorno depressivo maior
BR112018072530A2 (pt) variantes de protease e usos das mesmas
BR112016023613A2 (pt) novo bacteriófago e composição compreendendo o mesmo
BR112018074718A2 (pt) composição líquida não oleosa, não aquosa, e, método de controle de nematódeos.
BR112014019399A2 (pt) métodos de tratamento da fibrose
BR112019004168A2 (pt) hidrato cristalino, composição farmacêutica, e, método de tratamento de uma doença ou condição
BR112018069927A2 (pt) terapia de câncer com um vírus oncolítico combinado com um inibidor de ponto de verificação
CL2022000967A1 (es) Composiciones y métodos para el tratamiento de enfermedades hepáticas
CO2022000270A2 (es) Inhibidores de enzimas